类风湿关节炎疾病活动度预测新发临床显性RA相关间质性肺病:前瞻性队列研究
基于Brigham RA序贯研究(BRASS,2003-2016)的前瞻性队列,纳入1419例基线无RA-ILD的RA患者,随访期间识别85例新发RA-ILD。 annually更新的DAS28显示,中/高疾病活动度组较缓解/低活动度组发生RA-ILD的多变量HR为2.22(95%CI 1.28-3.82),且风险随疾病活动度类别升高而增加(P for trend=0.001)。
要点
- 中/高疾病活动度RA患者发生RA-ILD的风险是缓解/低活动度组的2.22倍(95%CI 1.28-3.82)。
- DAS28每增加1个单位,RA-ILD风险增加35%(95%CI 14-60%)。
- RA-ILD风险随疾病活动度类别升高呈递增趋势(P for trend=0.001)。
核心结论
- 活动性关节型RA与发生RA-ILD的风险增加相关。
- 结果提示降低全身性炎症可能改变RA-ILD发生的自然史。
研究设计与样本
- 前瞻性队列研究,使用Brigham RA序贯研究(BRASS,2003-2016)数据。
- 纳入1419例符合公认标准诊断为RA且基线无RA-ILD的患者,每年前瞻性测量DAS28及协变量数据。
- RA-ILD诊断由临床指征胸部CT图像复核确定,采用Cox回归估计HR和95%CI。
主要发现
- 1419例参与者平均±SD年龄55.8±14.2岁,68.6%为抗CCP抗体或类风湿因子血清阳性。
- 平均±SD每例随访8.9±4.2年期间,识别85例新发RA-ILD。
- 中/高疾病活动度组较缓解/低活动度组发生RA-ILD的多变量HR为2.22(95%CI 1.28-3.82)。
- 按疾病活动度类别,缓解组多变量HR为1.00(参考),低活动度组1.41(95%CI 0.61-3.28),中活动度组2.08(95%CI 1.06-4.05),高活动度组3.48(95%CI 1.64-7.38),P for trend=0.001。
- DAS28每增加1个单位,RA-ILD风险增加35%(95%CI 14-60%)。
关键数值与推荐
- 多变量模型调整了已知RA-ILD风险因素:年龄、性别、吸烟状态、RA病程和血清学状态。
- 替代分析未在缺失DAS28数据时删失,并额外调整甲氨蝶呤使用、糖皮质激素使用、骨侵蚀存在和类风湿结节存在,结果相似。
临床怎么用
- 对RA患者应积极控制疾病活动度,中/高活动度与RA-ILD风险增加独立相关。
- 定期评估DAS28可能有助于识别RA-ILD高风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate rheumatoid arthritis (RA) disease activity and risk of RA-associated interstitial lung disease (RA-ILD). METHODS: We investigated disease activity and risk of RA-ILD using the Brigham RA Sequential Study (BRASS, 2003-2016). All patients were diagnosed as having RA according to accepted criteria. Disease Activity Scores in 28 joints (DAS28) and covariate data were measured prospectively at annual study visits. Diagnosis of RA-ILD was determined by review of images from clinically indicated chest computed tomography scans. We analyzed patients without RA-ILD at baseline. We used Cox regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for RA-ILD, using annually updated DAS28 data, with adjustment for known RA-ILD risk factors (age, sex, smoking status, RA duration, and serologic status). We performed alternative analyses that did not censor at the time of missing DAS28 data and included adjustment for use of methotrexate, use of glucocorticoids, presence of bone erosions, and presence of rheumatoid nodules. RESULTS: Among 1,419 participants, the mean ± SD age was 55.8 ± 14.2 years, and 68.6% were seropositive for either cyclic citrullinated peptide or rheumatoid factor. We identified 85 incident cases of RA-ILD during a mean ± SD follow-up duration of 8.9 ± 4.2 years per patient. The moderate/high disease activity group had a multivariable HR of 2.22 (95% CI 1.28-3.82) for RA-ILD compared to the remission/low disease activity group. Risk of RA-ILD increased across disease activity categories: multivariable HR 1.00 (reference) for remission, 1.41 (95% CI 0.61-3.28) for low disease activity, 2.08 (95% CI 1.06-4.05) for moderate disease activity, and 3.48 (95% CI 1.64-7.38) for high disease activity (P for trend = 0.001). For each unit increase in the DAS28, the risk of RA-ILD increased by 35% (95% CI 14-60%). Results were similar in analyses that included follow-up for missing DAS28 data and with adjustment for use of methotrexate, use of glucocorticoids, presence of bone erosions, or presence of rheumatoid nodules. CONCLUSION: Active articular RA was associated with an increased risk of developing RA-ILD. These results suggest that decreasing systemic inflammation may alter the natural history of RA-ILD development.
引用
- Sparks JA, He X, Huang J, et al. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study. Arthritis Rheumatol. 2019. PMID: 30951251. doi:10.1002/art.40904
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。